rapt.com (RAPT): Market Value

RAPT Therapeutics, Inc. (RAPT) leverages a biotech platform in the oncology field, developing molecules for subsequent sale to industry giants. The market capitalization trend, which currently stands at 0.98, reflects the asset's price action. The business is limited by the trial stage and remains dependent on regulatory verdicts. Meanwhile, the company strictly adheres to environmental standards, minimizing toxic emissions and optimizing transport chains.

RAPT (RAPT Therapeutics, Inc.) Market Value history from 07/04/2022 to 03/14/2026

Comprehensive metric breakdowns and analytics for RAPT Therapeutics Inc. (RAPT)

- current price and projected stock value:

Stock Price RAPT Therapeutics|RAPT - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value RAPT Therapeutics, Inc.|RAPT - Full Business Value

- book value of equity indicators:

Accounting Value per Share RAPT Therapeutics|RAPT - Total Net Assets|Market Value to Book Value Ratio rapt.com|RAPT - Total Asset Value of Company

- debt burden and liquidity indicators:

Total Debt to Capital RAPT Therapeutics, Inc.|RAPT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital RAPT Therapeutics, Inc.|RAPT - Company Aggregate Debts|Debt to Book Capitalization Ratio RAPT Therapeutics, Inc.|RAPT - Company Long-Term Loans and Borrowings|Company Short-Term Debt RAPT Therapeutics|Quick Ratio rapt.com

- net income and valuation multiples indicators:

RAPT - Net Profit|Future Profit RAPT Therapeutics, Inc.|RAPT - Company Value to Net Income|Forward P/E Multiple RAPT Therapeutics|RAPT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RAPT Therapeutics, Inc.|RAPT - Operating profit before deduction of amortization|Earnings per share for the last twelve months RAPT Therapeutics|RAPT - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months rapt.com|RAPT - Earnings growth in current year|Net earnings per share growth forecast for next year RAPT Therapeutics, Inc.

- issuer revenue and sales details:

RAPT - Company Sales Volume|Projected Sales Volume RAPT Therapeutics, Inc.|RAPT - Price to Sales|Price-to-Projected Revenue Ratio RAPT Therapeutics, Inc.

Fundamental company analysis:RAPT (RAPT Therapeutics)

Product sample of RAPT Therapeutics Inc.

Market capitalization reflects the total volume of invested capital, determining the scale of institutional confidence in the asset. This metric is calculated as the product of the current share price and the total number of issued securities. By analyzing the issuer's market value, an investor identifies the long-term development vector of the business. For RAPT Therapeutics, Inc. (RAPT), growth in this value confirms success in immunology. Stable capitalization dynamics allow the company to finance the implementation of eco-friendly filtration systems and ESG optimization of logistics.

Key competitors